SEARCH

SEARCH BY CITATION

References

  • 1
    Aisner, J., Schimpff, S., Wiernik, H. (1977) Treatment of invasive aspergillosis: relation of early diagnosis and treatment response. Annals of Internal Medicine, 86, 539 543.
  • 2
    Aquino, V.M., Pappo, A., Buchanan, G.R., Tkaczewski, I., Mustafa, M.M. (1995) The changing epidemiology of bacteraemia in neutropenic children with cancer. Pediatric Infectious Disease Journal, 14, 140 143.
  • 3
    Armstrong, D., Young, L.S., Meyer, R.D., Blevins, A.H. (1971) Infectious complications of neoplastic disease. Medical Clinics of North America, 55, 729 745.
  • 4
    Beck-Sagué, C.M. & Jarvis, W.R., and the National Nosocomial Infections Surveillance System (1993) Secular trends in the epidemiology of nonsocomial fungal infections in the United States, 1980–1990. Journal of Infectious Diseases, 167, 1247 1251.
  • 5
    Bodey, G., Bueltmann, B., Duguid, W., Gibbs, D., Hanak, H., Hotchi, M., Mall, G., Martino, P., Meunier, F., Milliken, S., Naoe, S., Okudaira, M., Scevola, D., Van't Wout, J. (1992) Fungal infections in cancer patients: an international autopsy survey. European Journal of Clinical Microbiology and Infectious Diseases, 11, 99 109.
  • 6
    Bodey, G.P., Buckley, M., Sathe, Y.S., Freireich, E.J. (1966) Quantitative relationship between circulating leukocytes and infection in patients with acute leukemia. Annals of Internal Medicine, 64, 328 340.
  • 7
    Boogaerts, M.A., Verhoef, G.E., Zachee, G.E., Demuynck, H., Verbist, L., DeBeule, K. (1989) Antifungal prophylaxis with itraconazole in prolonged neutropenia: correlation with plasma levels. Mycoses, 32, (Suppl. 1), 103 108.
  • 8
    Bow, E.J., Loewen, R., Vaughan, D. (1995) Reduced requirement of gram-negative antibiotic therapy in febrile neutropenic patients with cancer who are receiving antibacterial chemoprophylaxis with oral quinolones. Clinical Infectious Diseases, 20, 907 912.
  • 9
    Brown, A.E., Kiehn, T.E., Armstrong, D. (1995) Bacterial resistance in the patient with neoplastic disease. Infectious Diseases in Clinical Practice, 4, (Suppl. 3), S136 S144.
  • 10
    Burke, P.J., Braine, H.G., Rathburn, H.K., Owens, A.H. (1976) The clinical significance and management of fever in acute myelocytic leukemia. Johns Hopkins Medical Journal, 139, 1 12.
  • 11
    Castagnola, E. & Viscoli, C. (1997) Gram-positive infections and quinolones in neutropenia. (Letter). Annals of Internal Medicine, 126, 830.
  • 12
    Cohen, K.J., Leamer, K., Odom, L., Greffe, B., Stork, L. (1995) Cessation of antibodies regardless of ANC is safe in children with febrile neutropenia. Journal of Pediatric Hematology and Oncology, 17, 325 330.
  • 13
    Cometta, A., Calandra, T., Bille, J., Glauser, M.P. (1994) Escherichia coli resistant to fluoroquinolone prophylaxis in patients with cancer and neutropenia. (Letter). New England Journal of Medicine, 330, 1240 1241.
  • 14
    Cometta, A., Calandra, T., Gaya, H., Zinner, S.H., De Bock, R., Del Favero, A., Bucaneve, G., Crokaert, F., Kern, W.V., Klastersky, J., Langenaeken, J., Micozzi, A., Padmos, A., Paesmans, M., Viscoli, C., Glauser, M.P. (1996) Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. Antimicrobial Agents and Chemotherapy, 40, 1108 1115.
  • 15
    Cometta, A., Zinner, S., De Bock, R., Calandra, T., Gaya, H., Klastersky, J., Langenaeken, J., Paesmans, M., Viscoli, C., Glauser, M.P. (1995) Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. Antimicrobial Agents and Chemotherapy, 39, 445 452.
  • 16
    Corey, L. & Spear, P.G. (1986) Infections with herpes simplex viruses. New England Journal of Medicine, 106, 749 757.
  • 17
    Cruciani, M., Rampazzo, R., Malena, M., Lazzarini, L., Todeschini, G., Messori, A., Concia, E. (1996) Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis. Clinical Infectious Diseases, 23, 795 805.
  • 18
    De Pauw, B.E., Deresinski, S.C., Feld, R., Lane-Allman, E.F., Donnelly, P. (1994) Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. Annals of Internal Medicine, 120, 834 844.
  • 19
    Del Favero, A., Menichetti, F., Guerciolini, R., Bucaneve, G., Baldelli, F., Aversa, F., Terenzi, A., Davis, S., Pauluzzi, S. (1987) Prospective randomised clinical trial of teicoplanin for empiric combined antibiotic therapy in a febrile granulocytopenic acute leukemia patient. Antimicrobial Agents and Chemotherapy, 31, 1126 1129.
  • 20
    Di Nubile, M.J. (1988) Stopping antibiotic therapy in neutropenic patients. Annals of Internal Medicine, 108, 289 292.
  • 21
    Donnelly, J.P. (1995) Chemoprophylaxis for the prevention of bacterial and fungal infections. Infectious Complications of Cancer (ed. by J. Klastersky), pp. 45 82. Kluwer Academic, Norwell.
  • 22
    Edwards, J.E., Jr , Bodey, G.P., Bowden, R.A., Buchner, T., De Pauw, B.E., Filler, S.G., Ghannoum, M.A., Glauser, M., Herbrecht, R., Kauffman, C.A., Kohno, S., Martino, P., Meunier, F., Mori, T., Pfaller, M.A., Rex, J.H., Rogers, T.R., Rubin, R.H., Solomkin, J., Viscoli, C., Walsh, T.J., White, M. (1997) International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. Clinical Infectious Diseases, 25, 43 59.
  • 23
    Elting, L.S., Bodey, G.P., Keefe, B.H. (1992) Septicemia and shock syndrome due to viridans streptococci: a case control study of predisposing factors. Clinical Infectious Diseases, 14, 1201 1207.
  • 24
    EORTC–International Antimicrobial Therapy Cooperative Group (1989) Empiric antifungal therapy in febrile granulocytopenic patients. American Journal of Medicine, 86, 668 672.
  • 25
    EORTC–International Antimicrobial Therapy Cooperative Group (1990) Gram-positive bacteraemia in granulocytopenic cancer patients. European Journal of Cancer, 26, 569 574.
  • 26
    EORTC–International Antimicrobial Therapy Co-operative Group (1993) Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. Annals of Internal Medicine, 119, 584 593.
  • 27
    EORTC–International Antimicrobial Therapy Co-operative Group (1994) Reduction of fever and streptococcal bacteremia in granulocytopenic patients with cancer. Journal of the American Medical Association, 19, 1183 1189.
  • 28
    EORTC–International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada–Clinical Trials Group (1991) Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. Journal of Infectious Diseases, 163, 951 958.
  • 29
    EORTC–International Antimicrobial Therapy Project Group (1978) Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. Journal of Infectious Diseases, 137, 14 29.
  • 30
    Fan Havard, P., Capano, D., Smith, S.M., Mangia, A., Eng, H.K. (1991) Development of resistance in Candida isolates from patients receiving prolonged antifungal therapy. Antimicrobial Agents and Chemotherapy, 35, 2302 2305.
  • 31
    Freifield, A.G., Walsh, T., Marshall, D., Gress, J., Steinberg, S.M., Hathorn, J., Rubin, M., Jarosinski, P., Fill, V., Young, R.C. (1995) Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem. Journal of Clinical Oncology, 13, 165 176.
  • 32
    Gold, H.S. & Moellering, R.C. (1996) Antimicrobial-drug resistance. New England Journal of Medicine, 335, 1445 1453.
  • 33
    Goodman, J.L., Winston, D.J., Greenfield, R.A., Chandrasekar, P.H., Fox, B., Kaizer, H., Shadduck, R.K., Shea, T.C., Stiff, P., Friedman, D.J., Powderly, W.G., Silber, J.L., Horowitz, H., Lichtin, A., Wolff, S.N., Mangan, K.F., Silver, S.M., Weisdorf, D., Ho, W.G., Gilbert, G., Buell, D. (1992) A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. New England Journal of Medicine, 326, 845 851.
  • 34
    Groll, A., Shah, P.M., Mentzel, C., Schneider, M., Just Neubling, G., Huebner, K. (1996) Trends in the post-mortem epidemiology of invasive fungal infections at a University Hospital. Journal of Infections, 33, 23 32.
  • 35
    Guiot, H.F.L., Van den Broak, J., Van der Meer, J.W.M., Van Furth, R. (1983) Selective antimicrobial modulation of the intestinal flora of patients with acute nonlymphocytic leukemia: a double-blind, placebo-controlled study. Journal of Infectious Diseases, 147, 615 623.
  • 36
    Hann, I., Viscoli, C., Paesmans, M., Gaya, H., Glauser, M. (1997) A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. British Journal of Haematology, 99, 580 588.
  • 37
    Hathorn, J.W. (1993) Critical appraisal of antimicrobials for prevention of infections in immunocompromised hosts. Hematology/Oncology Clinics of North America, 7, 1051 1099.
  • 38
    Hughes, W.T., Armstrong, D., Bodey, G.P., Brown, A.E., Edwards, J.E., Feld, R., Pizzo, P., Rolston, K.V.I., Shenep, J.L., Young, L.S. (1997) Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clinical Infectious Diseases, 25, 551 573.
  • 39
    Hughes, W.T., Armstrong, D., Bodey, G.P., Feld, R., Mendell, G.L., Meyers, J.D., Pizzo, P.A., Schimpff, S.C., Shenep, J.L., Wade, J.C. (1990) Guidelines for the use of antimicrobial agents in neutropenia patients with unexplained fever. Journal of Infectious Diseases, 161, 381 396.
  • 40
    Karp, J.E., Burch, P., Mertz, M.G. (1988) An approach to intensive antileukemia therapy in patients with previous invasive aspergillosis. American Journal of Medicine, 85, 203 209.
  • 41
    Karp, J.E., Dick, C., Angelopulos, C., Charache, P., Green, L., Burke, R., Saral, R. (1986) Empiric use of vancomycin during prolonged treatment induced granulocytopenia: randomized double-blind, placebo controlled trial in patients with acute leukemia. American Journal of Medicine, 81, 237 242.
  • 42
    Kern, W., Andriof, E., Oethinger, M., Kern, P., Hacker, J., Marre, R. (1994) Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center. Antimicrobial Agents and Chemotherapy, 38, 681 687.
  • 43
    Klastersky, J. (1986) Concept of empiric therapy with antibiotic combinations: indications and limits. American Journal of Medicine, 80, (Suppl. 5C), 2 12.
  • 44
    Klastersky, J., Zinner, S.H., Calandra, T., Gaya, H., Glauser, M.P., Meunier, F., Rossi, M., Schimpff, S.C., Tattersall, M., Viscoli, C. (1988) Empiric antimicrobial therapy for febrile, granulocytopenic cancer patients: lesson from four EORTC trails. European Journal of Cancer and Clinical Oncology, 24, (Suppl. 1), S35 S45.
  • 45
    Kotilainen, P., Nikoskelainen, J., Huovien, P. (1990) Emergence of ciprofloxacin-resistant coagulase negative staphylococcal skin flora in immunocompromised patients receiving ciptofloxacin. Journal of Infectious Diseases, 161, 41 44.
  • 46
    Lau, R.C., Doyle, J.J., Freedman, M.H., King, S.M., Richardson, S.E. (1994) Early discharge of pediatric febrile neutropenic cancer patients by substitution of oral for intravenous antibiotics. Pediatric Haematology and Oncology, 11, 417 421.
  • 47
    Lucas, K.G., Brown, A.E., Armstrong, D., Chapman, D., Heller, G. (1996) The identification of febrile, neutropenic children at low risk for bacteraemia and complications of sepsis. Cancer, 77, 791 798.
  • 48
    Malik, L.A., Khan, W.A., Aziz, A., Karim, M. (1994) Self-administered antibiotic therapy for chemotherapy-induced, low-risk febrile neutropenia in patients with nonhematologic neoplasms. Clinical Infectious Diseases, 19, 522 527.
  • 49
    Martino, P., Girmenia, C., Micozzi, A., Raccah, R., Gentile, G., Venditti, M., Mandelli, F. (1993) Fungemia in patients with leukemia. American Journal of Medical Sciences, 306, 225 232.
  • 50
    Martino, P., Girmenia, C., Raccah, R., Micozzi, A., Cimino, G., Sgadari, C., Gentile, G. (1992) Single daily dose ceftriaxone plus amikacin treatment of febrile episodes in neutropenic patients attending day hospital for hematologic malignancies. Oncology, 49, 49 52.
  • 51
    McCabe, W.R. & Jackson, G.G. (1962) Gram-negative bacteraemia. II. Clinical, laboratory and therapeutic observations. Archives of Internal Medicine, 110, 856 864.
  • 52
    Menichetti, F., Del Favero, A., Martino, P., Bucaneve, G., Micozzi, A., D'Antonio, D., Ricci, P., Carotenuto, M., Liso, V., Nosari, A.M. (1994) Preventing fungal infections in granulocytopenic patients with acute leukemia: fluconazole compared with oral amphotericin B. Annals of Internal Medicine, 120, 913 918.
  • 53
    Meunier, F., Aoun, M., Bitar, N. (1992) Candidemia in immunocompromised patients. Clinical Infectious Diseases, 14, S120 S125.
  • 54
    Meyers, J. & Thomas, E.D. (1988) Infection complicating bone marrow transplantation. Clinical Approach to Infection in the Compromised Patient (ed. by R. H. Rubin and L. S. Young), pp. 525 556. Plenum Press, New York.
  • 55
    Micozzi, A., Nucci, M., Venditti, M., Gentile, G., Girmenia, C., Meloni, G., Martino, P. (1993) Piperacillin, tazobactam, amikacin versus piperacillin, tazobactam, amikacin and teicoplanin in the empirical treatment of neutropenic patients. European Journal of Microbiology and Infectious Diseases, 12, 1 8.
  • 56
    Morittu, L., Earl, H.M., Souhami, R.L., Ash, C.M., Tobias, J.S., Geddes, D.M., Harper, P.G., Spiro, S.G. (1989) Patients at risk of chemotherapy-associated toxicity in small cell lung cancer. British Journal of Cancer, 59, 801 804.
  • 57
    Mullen, C.A. & Buchanan, G.R. (1990) Early discharge of children with cancer treated for fever and neutropenia: identification and management of the low-risk patient. Journal of Clinical Oncology, 8, 1998 2004.
  • 58
    Murphy, M., Brown, A.E., Sepkowitz, K.A., Bernard, E.M., Kiehn, T.E., Armstrong, D. (1997) Fluoroquinolone prophylaxis for the prevention of bacterial infections in patients with cancer — is it justified? (Letter). Clinical Infectious Diseases, 25, 346 347.
  • 59
    Ninane, J., and a Multicentre Study Group (1994) A multicentre study of fluconazole versus oral polyenes in the prevention of fungal infections in children with hematological or oncological malignancies. European Journal of Clinical Microbiology and Infectious Diseases, 13, 330 337.
  • 60
    Perfect, J.R., Klotman, M.E., Gilbert, C., Crawford, D.D., Rosner, G.L., Wright, K.A., Peters, W.P. (1992) Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients. Journal of Infectious Disease, 165, 891 897.
  • 61
    Pizzo, P.A. (1993) Management of fever in patients with cancer and treatment-induced neutropenia. New England Journal of Medicine, 328, 1323 1332.
  • 62
    Pizzo, P.A., Hathorn, J.V., Hiemenz, J., Browne, M., Commers, J., Cotton, D., Gress, J., Longo, D., Marshall, D., McKnight, J. (1986) A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. New England Journal of Medicine, 315, 552 558.
  • 63
    Pizzo, P.A. & Meyers, J. (1989) Infections in the cancer patient. Principles and Practice of Oncology (ed. by V. T. De Vita, S. Hellman and S. A. Rosenbreg), pp. 2088 2133. Lippincott, Philadelphia.
  • 64
    Pizzo, P.A., Robichaud, K.J., Gill, F.A., Witebsky, F.G. (1982) Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. American Journal of Medicine, 72, 101 111.
  • 65
    Rains, C.P., Bryson, H.M., Peters, D.H. (1995) Ceftazidime: an update on its antibacterial activity, pharmacokinetic properties and therapeutic efficacy. Drugs, 49, 577 617.
  • 66
    Rubenstein, E.B., Rolston, K., Benjamin, R.S., Loewy, J., Escalante, C., Manzullo, E., Hughes, P., Moreland, B., Fender, A., Kennedy, K., Holmes, F., Elting, L., Bodey, G.P. (1993) Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer. Cancer, 71, 3640 3646.
  • 67
    Rubin, M., Hathorn, J.W., Marshall, D., Gress, J., Steinberg, S.M., Pizzo, P.A. (1988) Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia. Annals of Internal Medicine, 108, 30 35.
  • 68
    Schimpff, S., Satterlee, W.M., Young, V.M. (1971) Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. New England Journal of Medicine, 284, 1061 1075.
  • 69
    Schimpff, S.C., Green, W.H., Young, V.M., Fortner, C.L., Cusack, N., Block, J.B., Wiernik, P.H. (1975) Infectious prevention in acute nonlymphocytic leukemia: laminar airflow room reverse isolation with oral nonabsorbable antibiotics prophylaxis. Annals of Internal Medicine, 82, 351 358.
  • 70
    Schimpff, S.C., Young, V., Greene, E., Vermeulen, G.D., Moody, M.R., Wiernik, P.H. (1972) Origin of infection in acute non-lymphocytic leukemia: significance of hospital acquisition of potential pathogens. Annals of Internal Medicine, 77, 707 715.
  • 71
    Shenep, J., Hughes, W.T., Robertson, P.K., Blankenship, K., Baker, D., Meyer, W.H., Gigliotti, F., Sixbey, J.W., Santana, V.M., Feldman, S., Lott, L. (1988) Vancomycin, ticarcillin and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile neutropenic children with cancer. New England Journal of Medicine, 319, 1053 1058.
  • 72
    Sherertz, R.J., Belani, A., Kramer, B.S., Elfenbein, G.J., Weiner, R.S., Sullivan, M.L., Thomas, R.G., Samsa, G.P. (1987) Impact of air filtration on nosocomial Aspergillus infections: unique risk of bone marrow transplant recipients. American Journal of Medicine, 83, 709 718.
  • 73
    Slavin, M.A., Osborne, B., Adams, R., Levenstein, M.J., Schoch, H.G., Feldman, A.R., Meyers,, J.D., Bowden, R. (1995) Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation: a prospective, randomized, double-blind study. Journal of Infectious Diseases, 171, 1545 1552.
  • 74
    Sundararajan, V., Rubenstein, E.B., Rolston, K.V.I., Elting, L.S. (1997) Controversies in new antibiotic therapy for ambulatory patients. Supportive Care in Cancer, 5, 358 364.
  • 75
    Swartz, M. (1997) Use of antimicrobial agents and drug resistance. New England Journal of Medicine, 337, 491 492.
  • 76
    Talcott, J.A., Siegel, R.D., Finberg, R., Goldman, L. (1992) Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. Journal of Clinical Oncology, 10, 316 322.
  • 77
    Talcott, J.A., Whalen, A., Clark, J., Rieker, P.P., Finberg, R. (1994) Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule. Journal of Clinical Oncology, 12, 107 114.
  • 78
    The GIMEMA Infection Program (1991) Prevention of bacterial infection in neutropenic patients with hematologic malignancies: a randomized multicenter trial comparing norfloxacin with ciprofloxacin. Annals of Internal Medicine, 115, 7 12.
  • 79
    Todeschini, G., Murari, C., Bonesi, R., Pizzolo, G., Amaddi, G., Ambrosetti, A., Ceru, S., Piacentini, I., Martini, N., Montresor, P. (1993) Oral itraconazole plus nasal amphotericin B for prophylaxis of invasive apsergillosis in patients with hematologic malignancies. European Journal of Clinical Microbiology and Infectious Diseases, 12, 614 618.
  • 80
    Tomiak, A.T., Yau, J.C., Huan, S.D., Cripps, M.C., Goel, R., Perrault, D.J., Bourcier, J.D., Prosser, I.A., Soltys, K.M., Evans, W.K., Stewart, D.J. (1994) Duration of intravenous antibiotics for patients with neutropenic fever. Annals of Oncology, 5, 441 445.
  • 81
    Viscoli, C., Bruzzi, P., Castagnola, E., Boni, L., and the International Antimicrobial Therapy Cooperative Group of the EORTC (1994) Factors associated with bacteraemia in febrile granulocytopenic cancer patients. European Journal of Cancer, 30A, 430 437.
  • 82
    Viscoli, C., Bruzzi, P., Glauser, M. (1995) An approach to the design and implementation of clinical trials of empirical antibiotic therapy in febrile and neutropenic cancer patients. European Journal of Cancer, 32, 2013 2022.
  • 83
    Viscoli, C. & Castagnola, E. (1995) Factors predisposing cancer patients to infection. Infectious Complications of Cancer, (ed. by J. Klastersky), pp. 1 30. Kluwer Academic, Norwell.
  • 84
    Viscoli, C., Castagnola, E., Machetti, M. (1997) Antifungal treatment in patients with cancer. Journal of Internal Medicine, 242, (Suppl. 740), 89 94.
  • 85
    Viscoli, C., Castagnola, E., Van Lint, M.T., Moroni, C., Garaventa, A., Rossi, M.R., Fanci, R., Menichetti, F., Caselli, D., Giacchino, M., Congiu, M. (1996) Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial. European Journal of Cancer, 32A, 814 820.
  • 86
    Viscoli, C., Moroni, C., Boni, L., Bruzzi, P., Comelli, A., Dini, G., Fabbri, A., Secondo, V., Terragna, A. (1991) Ceftazidime plus amikacin versus ceftazidime plus vancomycin as empiric therapy in febrile neutropenic children with cancer. Reviews of Infectious Diseases, 13, 397 404.
  • 87
    Viscoli, C., Van Der Auwera, P., Meunier, F. (1988) Gram-positive infections in granulocytopenic patients: an important issue? Journal of Antimicrobial Chemotherapy, 21, 149 156.
  • 88
    Wiblin, R.T. & Wenzel, R.P. (1995) Infection control for oncology. Infectious Complications of Cancer (ed. by J. Klastersky), pp. 83 100. Kluwer Academic, Norwell.
  • 89
    Wiernikowski, J.T., Rothney, M., Dawson, S., Andrew, M. (1991) Evaluation of a home intravenous antibiotic program in pediatric oncology. American Journal of Pediatric Hematology and Oncology, 13, 144 147.
  • 90
    Wingard, J.R., Merz, W.G., Rinaldi, M.G., Johnson, T.R., Karp, J.E., Saral, R. (1991) Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. New England Journal of Medicine, 325, 1274 1277.
  • 91
    Wingard, J.R., Merz, W.G., Rinaldi, M.G., Miller, C.B., Karp, J.E., Saral, R. (1993) Association of Torulopsis glabrata infection with fluconazole prophylaxis in neutropenic bone marrow transplant patients. Antimicrobial Agents and Chemotherapy, 37, 1847 1849.
  • 92
    Winston, D.J., Chandrasekar, P.H., Lazarus, H.M., Goodman, J.L., Silber, J.L., Horowitz, H., Shadduck, R.K., Rosenfeld, C.S., Ho, W.G., Islam, M.Z., Buell, D.N. (1993) Fluconazole prophylaxis of fungal infections in patients with acute leukemia: results of a randomized placebo-controlled, double-bind, multicenter trial. Annals of Internal Medicine, 118, 495 503.
  • 93
    Winston, D.J., Winston, G.H., Bruckner, D.A., Champlin, R.E. (1991) Beta-lactam antibiotic therapy in febrile granulocytopenic patients: a randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone. Annals of Internal Medicine, 115, 849 859.